Alyssa Johnson

发表

Increased production of a secreted glycoprotein in engineered CHO cells through amplification of a transcription factor

D. Kompala, Mark C. Mowry, M. Lipscomb, 2004, Cytotechnology.

Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer

Michael Wierer, Michal Bassani-Sternberg, Kristen Wroblewski, 2018, Cell.

Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis

E. Lengyel, A. Montag, S. Yamada, 2018, Oncogene.

WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer

E. Lengyel, A. Montag, K. Hayashi, 2014, Oncogene.

Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis.

E. Lengyel, A. Montag, J. Locasale, 2019, Cell metabolism.

Fibroblasts Mobilize Tumo r Cell Glycogen to Promote Proliferation and Metastasis Graphical Abstract Highlights

E. Lengyel, A. Montag, J. Locasale, 2018 .

Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.

E. Lengyel, Yilin Zhang, A. Mukherjee, 2015, American journal of obstetrics and gynecology.

Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth.

B. Bryan, D. Gleason, W. Callahan, 2010, Oncology reports.

Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer

E. Lengyel, A. Mukherjee, V. Shridhar, 2015, Oncotarget.